The current status of heroin prescription treatment for heroin dependence

Bibliography

• UNITED NATIONS OFFICE ON DRUGS AND CRIME (2004) World Drug Report 2004. United Nations Office on Drugs and Crime. Vienna, Austria.
   Google Scholar
• MURRAY CJ, LOPEZ AD: Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet (1997) 349:1436–1442.
   PubMed Web of Science ®Google Scholar
• BEWLEY-TAYLOR D: The United States and International Drug Control, 1907–1997, London and New York, Pinter (1999).
   Google Scholar
• HOME AFFAIRS SELECT COMMITTEE: The Government's drugs policy: is it working?United Kingdom. Home Affairs Select Committee, House of Commons (2002).
   Google Scholar
• NADELMANN EA: Drug prohibition in the United States: costs, consequences, and alternatives. Science (1989) 245:939–947.
   PubMed Web of Science ®Google Scholar
• RYDELL CP, EVERINGHAM SS: Controlling cocaine. Supply versus demand programs. Santa Monica, CA, Drug Policy Research Centre, RAND (1994).
   Google Scholar
• WARD J, MATTICK R, HALL W: Methadone Maintenance Treatment and other Opioid Replacement Therapies. Amsterdam, the Netherlands, Harwood Academic Publishers (1998).
   Google Scholar
• WORLD HEALTH ORGANIZATION, UNODC, UNAIDS: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper. Geneva, World Health Organization, United Nations Office on Drugs and Crime, UNAIDS (2004).
   Google Scholar
• CARTWRIGHT WS: Cost-benefit analysis of drug treatment services: review of the literature. I Ment. Health Policy Econ. (2000) 3:11–26.
   PubMedGoogle Scholar
• •A recent and comprehensive review of the literature on cost-benefit of drug treatment.
   Google Scholar
• KIRCHMAYER U, DAVOLI M, VERSTER A: Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst. Rev (2002) CD001333.
   Google Scholar
• FISCHER B, REHM J, KIRST M et al.: Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur. J. Public Health (2002) 12:228–234.
   PubMed Web of Science ®Google Scholar
• ••An excellent overview of the currentstatus of research into the use of heroin for treatment of heroin users covering countries where research has been completed or is underway and where future research is being considered.
   Google Scholar
• REUTER P, MACCOUN R: Heroin maintenance: Is a US experiment needed? In: Musto, D. (Ed.) One hundred years of heron. Westport, CT, Auburn House (2002) pp. 159–180.
   Google Scholar
• MUSTO DF: The American Disease: Origins of Narcotic Control, New York, Oxford University Press (1999).
   Google Scholar
• MINISTRY OF HEALTH DEPARTMENTAL COMMITTEE ON MORPHINE AND HEROIN ADDICTION: Chairman: Sir Humphrey D Rolleston (1926) Departmental Committee on Morphine and Heron Addiction: report. Ministry of Health, London, UK.
   Google Scholar
• LE DAIN G: Commission of Inquiry into the Non-Medical Use of Drugs, Ottawa, Information Canada (1973).
   Google Scholar
• FISCHER B, REHM J: The case for a heroin substitution treatment trial in Canada. Can. I Public Health (1997) 88:367–370
   PubMed Web of Science ®Google Scholar
• •The rationale for research into the use of heroin to treat heroin-dependent persons as argued in a major national Commission in Canada in 1973 and as perceived a quarter of a century later.
   Google Scholar
• METREBIAN N, CARNWATH T, STIMSON GV, STORZ T: Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction (2002) 97:1155–1161.
   PubMed Web of Science ®Google Scholar
• HARTNOLL RL, MITCHESON MC, BATTERSBY A et al. Evaluation of heroin maintenance in controlled trial. Arch. Gen. Psychiatry (1980) 37:877–884
   PubMed Web of Science ®Google Scholar
• MCCUSKER C, DAVIES M: Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team. Subst. Abuse Treat. (1996) 13:521–531.
   PubMed Web of Science ®Google Scholar
• VOTH EA, AESCHBACH E: Prescription of heroin to treatment resistant heroin addicts: heroin handouts are flawed policy. Br. Med. J. (2004) 328:229.
   PubMed Web of Science ®Google Scholar
• SATEL SL, AESCHBACH E: The Swiss heroin trials: scientifically sound?Subst. Abuse Treat. (1999) 17:331–335.
   PubMed Web of Science ®Google Scholar
• BAMMER G, DOBLER-MIKOLA A, FLEMING PM, STRANG J, UCHTENHAGEN A: The heroin prescribing debate: integrating science and politics. Science (1999) 284:1277-1278. This paper summarises what had been learnt about the science and politics of HP after the Swiss trial had been completed and the Australian trial had been aborted.
   Google Scholar
• REHM J, GSCHWEND P, STEFFEN T et al.: Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet (2001) 358:1417–1420.
   PubMed Web of Science ®Google Scholar
• ••This is the major paper reporting resultsfrom the Swiss effectiveness study of HP.
   Google Scholar
• ALT R, AURIACOMBE M, CASAS M et al.: Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts. Sucht (1999) 45:160–170.
   Google Scholar
• STEFFEN T, BLATTLER R, GUTZWILLER F, ZWAHLEN M: HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. Eur. J. Public Health (2001) 11:425–430.
   PubMed Web of Science ®Google Scholar
• STEFFEN T, CHRISTEN S, BLATTLER R, GUTZWILLER F: Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE). Subst. Use Misuse (2001) 36:71–89.
   PubMed Web of Science ®Google Scholar
• GUTTINGER F, GSCHWEND P, SCHULTE B, REHM J, UCHTENHAGEN A: Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Eur. Addict Res. (2003) 9:73–79.
   PubMed Web of Science ®Google Scholar
• •Although the design of the Swiss trial made inferences of benefit difficult, these long-term impressive outcomes were observed in both patients still in treatment and those leaving after prolonged treatment.
   Google Scholar
• KILLIAS M, AEBI M, RIBEAUD D: Effects of heroin prescription on police contacts among drug-addicts. Eur. Crim. Poi Res. (1998) 6:433–438.
   Google Scholar
• PERNEGER TV, GINER F, DEL RIO M, MINO A: Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. Br. Med. J. (1998) 317:13–18.
   PubMed Web of Science ®Google Scholar
• VAN DEN BRINK W, HENDRIKS VM, BLANKEN P et al: Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. Br. Med. J. (2003) 327:310.
   PubMed Web of Science ®Google Scholar
• ••This is the major paper reportingimpressive results from the experimental groups compared with controls in the two carefully conducted RCTs in the Netherlands.
   Google Scholar
• BLANKEN P, HENDRIKS VM, KOETER MWJ, VAN REE J M, VAN DEN BRINK W: Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials. Addiction (2005) 100:89–95.
   PubMed Web of Science ®Google Scholar
• •The major finding in this study was that patients benefiting most from HP had previously been in abstinence treatment.
   Google Scholar
• VAN DEN BRINK WHV, VAN REE V: Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands. J. Drug Issues (1999) 29:587–608.
   Web of Science ®Google Scholar
• •An excellent, thoughtful overview of the rationale and background of the HP research in the Netherlands.
   Google Scholar
• FRET A, GREINER RA, MEHNERT A, DINKEL R: Socioeconomic evaluation of heroin maintenance treatment. In: Gutzwiller F, Steffen T (Eds.): Cost-benefit Analysis of Heroin Maintenance Treatment Karger Basel (2000).
   Google Scholar
• DIJKGRAAF MG, VAN DER ZANDEN BP, DE BORGIE CA, BLANKEN P, VAN REE JM, VAN DEN BRINK W: Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Br. Med. J. (2005) 330:1297.
   PubMed Web of Science ®Google Scholar
• MUSSHOFF F, TRAFKOWSKI J, MADEA B: Validated assay for the determination of markers of illicit heroin in urine samples for the control of patients in a heroin prescription programChromatogr. B. (2004) 811:47–52.
   Google Scholar
• FERRI M, DAVOLI M, PERUCCI CA: Heroin maintenance for chronic heroin dependents. Cochrane Database Syst. Rev (2003) CD003410.
   Google Scholar
• BAMMER G, VAN DEN BRINK W, GSCHWEND P, HENDRIKS V, REHM J: What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev (2003) 22(3):363–371.
   PubMed Web of Science ®Google Scholar
• ••A careful review of the current stateof knowledge of the unintended adverse consequences of HP.
   Google Scholar
• OSTINI R, BAMMER G, DANCE P, GOODIN R: The ethics of experimental heroin maintenance. J. Med. Ethics (1993) 19:175–182.
   PubMed Web of Science ®Google Scholar
• GSCHWEND P, REHM J, BLATTLER R et al: Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland. Swiss National Cohort Study.
   Google Scholar
• http://wholibdoc.who.int/hq/ 192005/ a87017.pdf Essential medicines WHO model list Explanatory notes, 14th Ed, p 21 (2005).
   Google Scholar